Jihong Liu
Sun Yat-sen University(CN)Sun Yat-sen University Cancer Center(CN)Tongji Hospital(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, Cervical Cancer and HPV Research, Cancer-related molecular mechanisms research
Most-Cited Works
- → Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial(2023)282 cited
- → Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer(2013)225 cited
- → Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial(2021)218 cited
- → Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆(2021)198 cited
- → A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12(2013)148 cited
- →